Comparing the 25 selected regions regarding the revenue in the 'Cold & Cough Remedies' segment of the otc pharmaceuticals market, the United States is leading the ranking (10.7 billion U.S. dollars) and is followed by China with 8.1 billion U.S. dollars. At the other end of the spectrum is Saudi Arabia with 111.49 million U.S. dollars, indicating a difference of 10.6 billion U.S. dollars to the United States.
Data provided by Statista Market Insights are estimates.
Definition: The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional Information: The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included. For more information on the data displayed, use the info button next to the boxes.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (December 2, 2024). Revenue of the cold & cough remedies market worldwide by country in 2023 (in million U.S. dollars) [Graph]. In Statista. Retrieved December 30, 2024, from https://www.statista.com/forecasts/758623/revenue-of-the-cold-and-cough-remedies-market-worldwide-by-country
Statista. "Revenue of the cold & cough remedies market worldwide by country in 2023 (in million U.S. dollars)." Chart. December 2, 2024. Statista. Accessed December 30, 2024. https://www.statista.com/forecasts/758623/revenue-of-the-cold-and-cough-remedies-market-worldwide-by-country
Statista. (2024). Revenue of the cold & cough remedies market worldwide by country in 2023 (in million U.S. dollars). Statista. Statista Inc.. Accessed: December 30, 2024. https://www.statista.com/forecasts/758623/revenue-of-the-cold-and-cough-remedies-market-worldwide-by-country
Statista. "Revenue of The Cold & Cough Remedies Market Worldwide by Country in 2023 (in Million U.S. Dollars)." Statista, Statista Inc., 2 Dec 2024, https://www.statista.com/forecasts/758623/revenue-of-the-cold-and-cough-remedies-market-worldwide-by-country
Statista, Revenue of the cold & cough remedies market worldwide by country in 2023 (in million U.S. dollars) Statista, https://www.statista.com/forecasts/758623/revenue-of-the-cold-and-cough-remedies-market-worldwide-by-country (last visited December 30, 2024)
Revenue of the cold & cough remedies market worldwide by country in 2023 (in million U.S. dollars) [Graph], Statista, December 2, 2024. [Online]. Available: https://www.statista.com/forecasts/758623/revenue-of-the-cold-and-cough-remedies-market-worldwide-by-country
